Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


InterMed Discovery and Biotropics Malaysia Berhad enter long-term strategic collaboration agreement


Dortmund, Germany, September 9, 2008 – InterMed Discovery (www.intermed-discovery.com), an emerging world class natural product lead-discovery company, and Biotropics Malaysia Berhad (www.biotropics-malaysia.com) a company promoting herbal based products from Malaysia, today announced a long-term Strategic Collaboration Agreement under which Biotropics will work with InterMed Discovery to investigate and commercialise products derived from Malaysia’s rich biodiversity and multicultural traditions. The two companies will seek to develop drugs, herbal medicines, nutritional supplements, functional foods, food ingredients, cosmetic ingredients, crop protection ingredients and other life sciences applications by exploring the extremely biodiversity-rich resources of Malaysia.

IMD will contribute its world leading expertise and technology platform for the discovery of natural products in order to build a proprietary portfolio of promising product candidates derived from naturally sourced materials from Malaysia. Biotropics will further develop these candidates into premium products for the world markets resulting in a mutually beneficial value generation for both companies.

“We are delighted to have this new agreement with Biotropics, which is a significant step forward in our sustainable business growth through integrated research-based value generation validating our strong research capabilities,” said Bernard Becker, Managing Director of InterMed Discovery. “It further opens business avenues and perspectives in to one of the most biodiverse countries and economically most dynamic regions in the world.”

“Malaysia is one of the most biodiversity-rich countries in the world, and this resource has been accessed for thousands of years on a local basis” said Dr Christof Jaenicke, CEO of Biotropics Malaysia Berhad, “With the help of InterMed Discovery we are positioned to commercialize this resource to the whole world while ensuring economic benefit for Malaysia in return.”

Notes for editors:

About InterMed Discovery
InterMed Discovery is an emerging world class natural product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries. Using one of the most powerful validated natural product discovery engines, InterMed Discovery generates proprietary product pipelines of early stage pharmaceuticals and functional ingredients and also supports partners in research and lead generation. Biologically characterised product leads are identified using IMD BIOPROFILING™ and NPSilico™, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on natural products. InterMed Discovery adds to this the industry’s largest collections of pure compounds, sample fractions and mixtures as its source for potential natural product leads. The Company is located in Dortmund, Germany and was founded in 2006 as a management buyout of the Natural Products Research Unit of Bayer Healthcare.
Further information on InterMed Discovery can be found at www.intermed-discovery.com .
About Biotropics Malaysia Berhard
Biotropics Malaysia Berhad (Biotropics), is a wholly owned subsidiary of Khazanah Nasional Berhad and was incorporated in February 2007. Khazanah is the strategic investment arm of the Government of Malaysia, whose mission is to manage the commercial assets held by the Government and to undertake strategic investments in new industries and geographies. Khazanah is also tasked with shaping selected strategic industries in Malaysia, nurture their development with the aim of pursuing the nation’s long-term economic interests. Biotropics’ role is to promote the growth of herbal-based products from Malaysia, to suit the needs of different consumers in the global marketplace. We aggregate and manage the value chain, from the sourcing of raw materials to processing, manufacturing, marketing and distribution of products to markets. With a strong emphasis on R&D, we want to ensure that our innovative products are scientifically tested and verified and meet the highest safety and quality standards globally.
For more information please visit www.biotropics-malaysia.com

About Biotropics’ projects
Malaysia is one of the most biodiversity-rich countries in the world. It is also blessed with huge swaths of tropical rainforests, which are more than a million years old. It was estimated that there could be more than 20,000 plant species in these forests, of which more than 2,000 are believed to have medicinal properties, which can be tapped. The richness of Malaysia’s flora are regarded as a form of ‘national treasure’ and upon further research, could hold the potential to be commercialised into high-value medicinal products and health supplements to enhance the quality of life. In addition to its rich biodiversity, Malaysia is also home to various ethnic groups who, over generations, have acquired intimate knowledge and practiced many forms of traditional medicine for healing and health maintenance. In spite of the diverse cultures, the common element was a strong emphasis on the usage of various parts of plants in their healing methods. With this unique national inheritance – a melting pot of knowledge, wisdom, traditional practices and an age-old culture in tune with nature and what it could offer – Malaysia has the advantage to leverage on this wealth of natural resources. Realising the vast commercial potential residing in this wealth of biological resources and traditional wisdom, Biotropics Malaysia Berhad was specifically set up to explore, harness and develop products utilising nature’s gift, for consumers around the world.
Further Information:

Erik Metz
Head of Business Development
InterMed Discovery GmbH
t: +49 (0)231 97 42 60 72
e: erik.metz@intermed-discovery.com

Douglas Pretsell
Account Director
College Hill Life Sciences
t: +49 (0)89 57 00 18 06
e: douglas.pretsell@collegehill.com


Publisher Contact Information:

InterMed Discovery GmbH (IMD)
+49 (0)231 97 42 60 72
erik.metz@intermed-discovery.com

Company profile of InterMed Discovery GmbH (IMD)
Past press releases of InterMed Discovery GmbH (IMD).

Data


26,231
Tech investments
From our Online Data Service
16,945
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Oct 11N/AInternet services
Oct 11€1.1MKnowledge management
Oct 11N/AInternet services
Oct 11€13.0MBiotechnology
Oct 11N/AMedical devices
Oct 10€50.0MInternet services
Oct 10€23.0MOther Computers & Electronics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.